Management of patients with autoimmune liver disease during COVID-19 pandemic.

Autor: Lleo A; Division of Internal Medicine and Hepatology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy; European Reference Network on Hepatological Diseases (ERN RARE-LIVER). Electronic address: ana.lleo@humanitas.it., Invernizzi P; European Reference Network on Hepatological Diseases (ERN RARE-LIVER); Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy., Lohse AW; European Reference Network on Hepatological Diseases (ERN RARE-LIVER); Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Aghemo A; Division of Internal Medicine and Hepatology, Humanitas Clinical and Research Center IRCCS, Rozzano, Milan, Italy; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy; European Reference Network on Hepatological Diseases (ERN RARE-LIVER)., Carbone M; European Reference Network on Hepatological Diseases (ERN RARE-LIVER); Division of Gastroenterology and Center for Autoimmune Liver Diseases, Department of Medicine and Surgery, University of Milan-Bicocca, Milan, Italy.
Jazyk: angličtina
Zdroj: Journal of hepatology [J Hepatol] 2020 Aug; Vol. 73 (2), pp. 453-455. Date of Electronic Publication: 2020 Apr 10.
DOI: 10.1016/j.jhep.2020.04.002
Abstrakt: Competing Interests: Conflict of interest Please refer to the accompanying ICMJE disclosure forms for further details.
Databáze: MEDLINE